NAGE FY 2008 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena

NAGENiagen Bioscience Inc

$386M

FY 2008 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M

Gross Profit

$1M27.3% margin

Operating Income

-$2M-45.8% margin

Net Income

-$2M-46.7% margin

EPS (Diluted)

$-0.22

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$121,185

Balance Sheet

Total Assets

$4M

Total Liabilities

$2M

Stockholders' Equity

$2M

Cash & Equivalents

$1M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$0	—
Gross Profit	$1M	$0	—
Operating Income	-$2M	-$38,382	-5277.5%
Net Income	-$2M	-$38,382	-5383.0%